The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 701–800 of 1,000
Li, H., Zhang, X., Xiang, C., Feng, C., Fan, C., Liu, M., Lu, H., Su, H., Zhou, Y., Qi, Q., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.02.006 · Cited by 27
Wang, P., Killeen, M. E., Sumpter, T. L., Ferris, L. K., Falo, L. D., Freeman, B. Α., Schopfer, F. J., & Mathers, A. R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101987 · Cited by 27
Coletto, L. A., Rizzo, C., Guggino, G., Caporali, R. F., Alivernini, S., & D’Agostino, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044108 · Cited by 27
“- IL-23/IL-17 axis (a regulator of G-CSF production) IL-17 inhibitors in PsO, PsA, ax-SpA; IL-12/23 inhibitors in PsO, PsA [133], CD, and SLE; IL-23 inhibitors in CD, UC, PsO, and PsA”
BackgroundControl of Giardiasis by Interleukin-17 in Humans and Mice—Are the Questions All Answered?
Singer, S. M. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00648-15 · Cited by 27
“rophage stimulating factor or IL-22 [27]) or the role of “Ex-Th17””
BackgroundDaniero, J. J., Ekbom, D. C., Gelbard, A. H., Akst, L. M., & Hillel, A. T. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2016.4126 · Cited by 27
Ramakrishna, C., & Cantin, E. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006822 · Cited by 27
The Disease Phenotype of Adenomyosis-Affected Women Correlates With Specific Serum Cytokine Profiles
Bourdon, M., Santulli, P., Chouzenoux, S., Maignien, C., Bailly, K., Andrieu, M., Millischer, A., Doridot, L., Marcellin, L., Batteux, F., et al. (2019) · Reproductive Sciences · doi:10.1177/1933719118816852 · Cited by 27
Low serum testosterone levels in male psoriasis patients correlate with disease severity
Allam, J., Bunzek, C., Schnell, L., Heltzel, M., Weckbecker, L., Wilsmann‐Theis, D., Brendes, K., Haidl, G., & Novak, N. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3605 · Cited by 27
“However, IL-17 has not only been linked to psoriasis but also to various autoimmune diseases such as multiple sclerosis, type 1 diabetes, and systemic lupus erythematodes (SLE) [9, 10].”
BackgroundSemaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner
Carvalheiro, T., Rafael‐Vidal, C., Malvar‐Fernández, B., Lopes, A. P., Pego‐Reigosa, J. M., Radstake, T. R. D. J., & García, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186965 · Cited by 27
“This role of Sema4A-PlexinD1 was observed in combination with key cytokines involved on Th differentiation, such as IL12 (Th1), IL-4 (Th2) and IL-23 (Th17) [4,5,9].”
BackgroundWang, R., & Maksymowych, W. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715510 · Cited by 27
Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies
Lutgens, E., Joffre, J., van Os, B. W., & Ait‐Oufella, H. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.024 · Cited by 28
Gooderham, M., Pinter, A., Ferris, L. K., Warren, R. B., Zhan, T., Zeng, J., Soliman, A. M., Kaufmann, C., Kaplan, B., Photowala, H., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18010 · Cited by 27
Moudgil, K. D. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.006 · Cited by 27
Redmond, A. K., Macqueen, D. J., & Dooley, H. (2018) · BMC Evolutionary Biology · doi:10.1186/s12862-018-1290-2 · Cited by 26
“IL-23R is a cytokine receptor specific to TH17 cells [8, 10, 12, 15].”
The Gut Microbiota: Emerging Evidence in Autoimmune and Inflammatory Diseases
Zeng, L., Yang, Q., Luo, Y., Luo, Y., & Sun, L. (2026) · Research · doi:10.34133/research.1097 · Cited by 27
“Excessive Th17 cell responses are closely linked to RA [ 145 , 146 ], and CIA mice exhibit compromised intestinal barrier function prior to arthritis onset, accompanied by elevated Th17-cell-related cytokines (IL-17A, IL-22, and IL-23) [ 147 ].”
Ma, Q., Ran, H., Li, Y., Lu, Y., Liu, X., Huang, H., Yang, W., Yu, L., Chen, P., Huang, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108492 · Cited by 26
Chaudhry, S. R., Kahlert, U. D., Kinfe, T. M., Endl, E., Dolf, A., Niemela, M. R., Hänggi, D., & Muhammad, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-92873-x · Cited by 26
Kusuda, M., Haroon, N., & Nakamura, A. (2021) · Modern Rheumatology · doi:10.1093/mr/roab057 · Cited by 26
Dendritic cells Trigger IFN‐γ secretion by NK cells independent of IL‐12 and IL‐18
Abdi, K., Laky, K., Abshari, M., Hill, E. M., Lantz, L. M., Singh, N. J., & Long, E. O. (2022) · European Journal of Immunology · doi:10.1002/eji.202149733 · Cited by 26
Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
Lim, S. H., Kim, K., & Choi, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081265 · Cited by 26
“IL-17 induces activation of the nuclear factor-κB, mitogen-activated protein kinases pathways, and the phosphoinositide-3 kinase pathway, leading to many inflammatory genes, mainly neutrophil-specific chemokines [162].”
BackgroundSu, Q. Y., Zheng, J., Yang, J.-Y., Zhang, T.-Y., Shan, S., Rong, Z., Di, J., Zhang, S., Wang, C., & Gao, H.-Y. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02240-z · Cited by 26
“Previous studies on the roles of IL-21 and the IL-17/IL-23 pathway in AS have reported inconsistent results [33].”
ResultIL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy
Park, A., & Heo, T. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121755 · Cited by 26
Colitis induced by IL-17A-inhibitors
Grümme, L., Dombret, S., Knösel, T., Skapenko, A., & Schulze‐Koops, H. (2023) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-023-01893-9 · Cited by 26
“IL-17A facilitates innate immunity by inducting chemokine and inflammatory cytokine production and by secreting antimicrobial peptides such as β-defensins, S100A8 and lipocalin 2 [2–4].”
BackgroundDifferentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Sun, X., Gu, R., & Bai, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05402-0 · Cited by 27
“Th17 cells are a newly discovered CD4 + T cell subset that mainly mediate the host’s immune response to extracellular bacterial and fungal infections through the secretion of IL-17 and other inflammatory cytokines [ 68–72 ].”
BackgroundTumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression
Chou, T.-F., Chuang, Y.-T., Hsieh, W., Chang, P.-Y., Liu, H., Mo, S.-T., Hsu, T.-S., Miaw, S., Chen, R., Kimchi, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11904 · Cited by 26
Seshadri, S., Allan, D., Carlyle, J. R., & Zenewicz, L. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006690 · Cited by 26
“STAT3 and AHR are important in the analogous adaptive immune system T helper 17 (Th17) subset [30].”
BackgroundSlivka, P. F., Hsieh, C.-L., Lipovsky, A. I., Pratt, S. D., Locklear, J., Namovic, M. T., McDonald, H. A., Wetter, J. B., Edelmayer, R. M., Hu, M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00260 · Cited by 26
Bogovič, P., Lusa, L., Korva, M., Lotrič‐Furlan, S., Rus, K. R., Pavletič, M., Avšič‐Županc, T., Strle, K., & Strle, F. (2019) · Microorganisms · doi:10.3390/microorganisms7110514 · Cited by 26
TCF-1 Inhibits IL-17 Gene Expression To Restrain Th17 Immunity in a Stage-Specific Manner
Zhang, J., He, Z., Sen, S., Wang, F., Zhang, Q., & Sun, Z. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800193 · Cited by 26
“Exaggerated Th17 responses are associated with many types of autoimmune diseases (8, 34).”
BackgroundTargeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity
Bühler, U., Schulenburg, K., Yurugi, H., Šolman, M., Abankwa, D., Ulges, A., Tenzer, S., Bopp, T., Thiede, B., Zipp, F., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899429 · Cited by 26
“While the contribution of Th17 cells towards the manifestation of autoimmune disorders is well established, the molecular signalling pathways that control the polarization and pathogenicity of Th17 cells have been intensively studied (Gaffen et al , 2014).”
Mashiko, S., Edelmayer, R. M., Bi, Y., Olson, L. M., Wetter, J. B., Wang, J., Maari, C., Proulx, É. S., Kaimal, V., Li, X., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.09.027 · Cited by 25
Guo, W., Xu, F., Zhuang, Z., Liu, Z., Xie, J., & Bai, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662362 · Cited by 25
IL-23 orchestrating immune cell activation in arthritis
Najm, A., & McInnes, I. B. (2021) · Rheumatology · doi:10.1093/rheumatology/keab266 · Cited by 25
Torres, T. R., Brembilla, N. C., Langley, R. G. B., Warren, R. B., Thaçi, D., Kolios, A. G. A., Prinz, J. C., Londoño, Á., Nast, A., Santín, M., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20287 · Cited by 25
“64 Like IL-17A, IL-23 seems implicated in protective responses to M. tuberculosis 65 ; however, its significance appears to be overshadowed by Th1 responses, being important only when the Th1/IFNγ axis is compromised.”
Sun, Z., Chen, X., Miao, F., Meng, N., Hu, K., Xiong, S., Peng, X., Ma, L., Zhou, C., & Yang, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s474536 · Cited by 25
Attiq, A., Afzal, S., Wahab, H. A., Ahmad, W., Kandeel, M. K., Almofti, Y. A., Alameen, A. O., & Wu, Y. S. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s475005 · Cited by 25
Lei, X., Xiao, R., Chen, Z., Ren, J., Zhao, W., Tang, W., Wen, K., Zhu, Y., Li, X., Ouyang, S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412120121 · Cited by 25
“The signaling pathways involving IL - 1 β , IL - 21, and IL - 23 are known to play crucial roles in the differentiation of Th17 cells and potentially contribute to the development of IL - 17A + IFN - γ + cells ( 45 – 48 ).”
Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis
Bilik, M. Z., Kaplan, İ., Polat, N., Akıl, M. A., Akyüz, A., Acet, H., Yüksel, M., İnci, Ü., Kayan, F., & Toprak, N. (2016) · Medicine · doi:10.1097/md.0000000000003562 · Cited by 25
“These agents also show hopeful results in ankylosing spondylitis and multiple sclerosis.(27) There is yet no specific treatment to prevent the progression of RHD.”
Backgroundon behalf of the Nordic Study Group of Pediatric Rheumatology (NoSPeR), Ekelund, M., Aalto, K. T., Fasth, A. L., Herlin, T., Nielsen, S., Nordal, E. B., Peltoniemi, S., Rygg, M., Zak, M., et al. (2017) · Pediatric Rheumatology · doi:10.1186/s12969-017-0145-5 · Cited by 25
“Immunology research has revealed that molecules of the interleukin-23 and interleukin-17 pathways promote skin and joint inflammation in psoriasis [5].”
BackgroundTing, J. P., Tung, F., Antonysamy, S., Wasserman, S. R., Jones, S. B., Zhang, F. F., Espada, A., Broughton, H. B., Chalmers, M. J., Woodman, M. E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190850 · Cited by 25
Jiang, Y., Tian, M., Lin, W., Wang, X., & Wang, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00921 · Cited by 25
Association of single-nucleotide polymorphisms in the IL27 gene with autoimmune thyroid diseases
He, W., Wang, B., Mu, K., Zhang, J., Yanping, Y., Yao, W., Li, S., & Zhang, J. (2019) · Endocrine Connections · doi:10.1530/ec-18-0370 · Cited by 25
Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors
Sun, L., Arbesman, J., & Piliang, M. P. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-020-02094-x · Cited by 25
IL-30† (IL-27A): a familiar stranger in immunity, inflammation, and cancer
Min, B., Kim, D., & Feige, M. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00630-x · Cited by 25
Marks, K. E., Flaherty, S., Patterson, K. M., Stratton, M. P., Martínez, G., & Reynolds, J. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109303 · Cited by 27
“Given that polarizing Th17 cells with TGF-β and IL-6 is not as potent for realizing inflammatory potential as compared to the IL-1β, IL-6, and IL-23 polarizing Th17 cell condition (Ghoreschi et al., 2010; McGeachy et al., 2009; Gaffen et al., 2014), we for the first time assessed the effect of TLR2 ligation on this mo…”
BackgroundPsoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy
Καραμανάκος, Α., Vergou, T., Panopoulos, S., Tektonidou, M. G., Stratigos, A., & Sfikakis, P. P. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.4056 · Cited by 25
Targeting Th17 cells in HIV-1 remission/cure interventions
Fert, A., Marchand, L. R., Salinas, T. R. W., & Ancuța, P. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.013 · Cited by 25
Debnath, M., Nagappa, M., Murari, G., & Taly, A. B. (2018) · Cytokine · doi:10.1016/j.cyto.2017.12.029 · Cited by 25
Fernandes, A. R., Martins‐Gomes, C., Santini, A., Silva, A. M., & Souto, E. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00009-7 · Cited by 26
C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins
Simpson-Abelson, M. R., Childs, E. E., Ferreira, M. C., Bishu, S., Conti, H. R., & Gaffen, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136538 · Cited by 24
“Although best known for its activation of pro-inflammatory signaling pathways such as NF-κB and MAPK, IL-17 also activates transcription factors (TFs) belonging to the CCAAT/Enhancer Binding Protein (C/EBP) family [10, 11].”
Self-citationNew immune cells in spondyloarthritis: Key players or innocent bystanders?
Venken, K., & Elewaut, D. S. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.02.002 · Cited by 24
Gammaherpesvirus Usurps Host IL-17 Signaling To Support the Establishment of Chronic Infection
Jondle, C. N., Johnson, K. E., Aurubin, C. A., Sylvester, P. A., Xin, G., Cui, W., Huppler, A. R., & Tarakanova, V. L. (2021) · mBio · doi:10.1128/mbio.00566-21 · Cited by 24
Cao, Z., Guo, J., Li, Q., Li, Y., & Wu, J. (2022) · BioMed Research International · doi:10.1155/2022/8316106 · Cited by 24
Sundarasivarao, P. Y. K., Walker, J. M., Rodríguez, A. R., Spur, B. W., & Yin, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011944 · Cited by 24
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
Zheng, M., Zhang, Z., Yu, L., Wang, Z., Dong, Y., Tong, A., & Yang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194421 · Cited by 24
Asukai, K., Kawamoto, K., Eguchi, H., Konno, M., Nishida, N., Koseki, J., Noguchi, K., Hasegawa, S., Ogawa, H., Yamada, D., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4782-y · Cited by 24
Su, Q., Zhang, X., Wang, D., Zhang, H., Zhu, C. G., Hou, Y., Liu, J., & Gao, Z. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.021 · Cited by 24
Poomarimuthu, M., Elango, S., Solomon, P. R., Soundrapandian, S., & Jayalakshmi, M. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1493053 · Cited by 24
“IL-23 signaling pathway plays a vital role in Th17 cell-mediated immune response and also in the pathogenesis of inflammatory and autoimmune diseases (Gaffen et al., 2014).”
BackgroundSo, A., & Inman, R. D. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.12.002 · Cited by 24
Guselkumab for the treatment of adults with moderate to severe plaque psoriasis
Puig, L. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1601014 · Cited by 24
“Binding of IL-23 to its receptor also stimulates Tyk2-mediated phosphorylation of the intracellular domain of IL-12Rβ1, phosphorylation of STAT4, and formation of STAT3-STAT4 heterodimers, as well as the degradation of the inhibitory subunit of nuclear factor kappa B alpha (IκBα) to induce activation of NF-κB [4].”
Zhu, K., Zhou, S., Xu, A., Sun, L., Li, M., Jiang, H., Zhang, B., Zeng, D., Fei, G., & Wang, R. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.017 · Cited by 24
“IL-17a is involved in the onset of many autoimmune diseases including multiple sclerosis and rheumatoid arthritis.(31) In this study, we enrolled smoking-related COPD patients and collected their sputum and peripheral blood samples.”
BackgroundAct Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
Kurilenko, N., Fatkhullina, A. R., Mazitova, A., & Koltsova, E. K. (2021) · Cells · doi:10.3390/cells10020348 · Cited by 25
“The Th17 immune response and the IL-23–IL-17A axis have been shown to be involved in the pathogenesis of various autoimmune diseases, including IBD [83].”
BackgroundInfluentialZhou, C., Wu, D., Jawale, C. V., Li, Y., Biswas, P. S., McGeachy, M. J., & Gaffen, S. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155715 · Cited by 24
Self-citationTh17 cells in the liver: balancing autoimmunity and pathogen defense
Taniki, N., Nakamoto, N., Chu, P., Ichikawa, M., Teratani, T., & Kanai∥, T. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00917-9 · Cited by 24
“1 3 This binding enables the recruitment of the adaptor protein ACT1, which activates the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways [18].”
BackgroundA critical role of Dectin-1 in hypersensitivity pneumonitis
Higashino-Kameda, M., Yabe‐Wada, T., Matsuba, S., Takeda, K., Anzawa, K., Mochizuki, T., Makimura, K., Saijo, S., Iwakura, Y., Toga, H., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0910-1 · Cited by 24
Guo, L., Lee, H. H., Noriega, M., Paust, H. J., Zahner, G., & Thaiss, F. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00242.2016 · Cited by 24
“These studies have suggested that c-Rel controls Th17 cell differentiation by inducing ROR and ROR t expression (7, 33).”
BackgroundŠkrlec, K., Zadravec, P., Hlavničková, M., Kuchař, M., Vaňková, L., Petroková, H., Křížová, L., Černý, J., Berlec, A., & Malý, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071933 · Cited by 24
“cell population by activation of IL-23 receptor-mediated signaling, leading to secretion of a cocktail of inflammatory mediators including IL-17, IL-22 and chemokines [6,7].”
BackgroundNeutrophilic Asthma—From Mechanisms to New Perspectives of Therapy
Iwaszko, I., Specjalski, K., Chełmińska, M., & Niedoszytko, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207137 · Cited by 23
“Moreover, IL-23 prolongs the expression of the listed Th17 cytokines that induce tissue pathology and chronic inflammatory diseases, giving prominence to the IL-23/IL-17 immune axis [146].”
Biologic Drugs for the Treatment of Noninfectious Uveitis
Ferreira, L. B., Smith, A. J., & Smith, J. R. (2021) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000371 · Cited by 23
“Interleukin-23 is an important cytokine for driving Th17 cell-related pathology.(91) The drug is administered via subcutaneous injections of 45 mg, repeated after 4 weeks and then at 8- to 12-week intervals, with an initial weight-based intravenous infusion in patients with inflammatory bowel disease.”
BackgroundNithiyanantham, S., Sankar, A., Hsu, H., Chung, C., Lee, C., Tsai, M., Yeh, K., Luo, S., & Ko, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119156 · Cited by 23
Theobald, L., Stroeder, R., Melchior, P., Iordache, I.-I., Tänzer, T., Port, M., Glombitza, B., Marx, S., Schub, D., Herr, C., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13095 · Cited by 23
Minohara, K., Imai, M., Matoba, T., Wing, J. B., Shime, H., Odanaka, M., Uraki, R., Kawakita, D., Toyama, T., Takahashi, S., et al. (2022) · Cancer Science · doi:10.1111/cas.15698 · Cited by 23
Mortier, C., Quintelier, K. L. A., Craemer, A. D., Renson, T., Deroo, L., Dumas, E., Verheugen, E., Coudenys, J., Decruy, T., Łukasik, Z. M., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42627 · Cited by 23
“…immune responses have been shown to be critically important in the pathogenesis of SpA and IBD, although therapeutic targeting of these cytokines leads to differential outcomes in both diseases, underscoring the complexity of combined gut and joint in fl ammation in SpA pathology ( 16 – 18).”
BackgroundCircular RNAs in inflammatory bowel disease
Lun, J., Guo, J., Yu, M., Zhang, H., & Fang, J. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1307985 · Cited by 24
“Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22, which are important in driving intestinal in fl ammation (61, 62).”
BackgroundInterplay between group A Streptococcus and host innate immune responses
Su, M. S., Cheng, Y., Lin, Y., & Wu, J.-J. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00052-22 · Cited by 23
“Following the GAS adhesion-induced signaling as described above, initial transform ing growth factor-β, interleukin (IL)-1β, IL-6, IL-21, and IL-23-dependent differentiated Th17 cells induce the production of pro-inflammatory cytokines [IL-1α, IL-1β, IL-2, IL-6, interferon (IFN)-β, TNF-α, and RANTES/CCL5] (115–119).”
BackgroundAxial Spondyloarthritis: an overview of the disease
Ivanova, M. G., Zimba, O., Dimitrov, I., Angelov, A. K., & Georgiev, T. (2024) · Rheumatology International · doi:10.1007/s00296-024-05601-9 · Cited by 23
“Moreover, numerous innate immune cells, including type 3 innate lymphoid cells (ILC3) and γδ T-cells, converge in skin, gut, entheseal, and ocular inflammation [73, 74].”
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice
Toth, K. A., Schmitt, E. G., Kolicheski, A., Greenberg, Z. J., Levendosky, E., Saucier, N., Trammel, K., Oikonomou, V., Lionakis, M. S., Klechevsky, E., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232091 · Cited by 23
Melatonin Lulling Th17 Cells to Sleep
Lee, J. S., & Cua, D. J. (2015) · Cell · doi:10.1016/j.cell.2015.08.054 · Cited by 23
“…subset of T helper cells, characterized by the production of the proinflammatory cytokine interleukin-17 (IL-17), with playing a central role in autoimmune diseases, including multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) (Gaffen et al., 2014).”
BackgroundSelf-citationSlit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes
Fernando, R., Atkins, S. J., & Smith, T. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900434 · Cited by 23
Zhou, X., Zhang, G., Ji, W., Shi, Z.-C., Ma, X., Luo, Z., & Wei, K.-J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626895 · Cited by 23
Targeting interleukin-17 as a novel treatment option for fibrotic diseases
Sisto, M., & Lisi, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010164 · Cited by 22
“In liver fibrosis, IL-17, operating in synergy with IL-1 β , IL-6, and IL-23, continues the inflammatory process by promoting transforming growth factor-β (TGF β ) expression in hepatic stellate cells [48,49].”
Samtsov, A. V., Khairutdinov, V. R., Bakulev, A. L., Kubanov, A. A., Karamova, A. Е., Artemeva, A. V., & Korotaeva, T. V. (2017) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2017-93-5-52-63 · Cited by 22
The role of inflammatory cytokines in the development of idiopathic subglottic stenosis
Motz, K., & Gelbard, A. H. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.37 · Cited by 22
“Stimulation of these cells by IL-23 induces local tissue inflammation, which is mainly mediated by IL-17A (25).”
BackgroundThe Role of IL-17 During Infections in the Female Reproductive Tract
Bagri, P., Anipindi, V. C., & Kaushic, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861444 · Cited by 22
Research progress of Ustekinumab in the treatment of inflammatory bowel disease
Zhang, W., Zhong, G., Ren, X., & Li, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1322054 · Cited by 22
“In addition to Th17 cells, natural immune cells that express ROR g t, such as subsets of gd T cells, NK T (NKT) cells, “ natural ” Th17 cells, and innate lymphoid cells (ILCs), also respond to IL-23 and have an essential role in both resisting infection and mediating autoimmune pathology (41).”
BackgroundBarin, J. G., Talor, M. V., Schaub, J. A., Diny, N. L., Hou, X., Hoyer, M., Archer, N. K., Gebremariam, E., Davis, M. F., Miller, L. S., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.001 · Cited by 22
Regulation of IL-17 by lncRNA of IRF-2 in the pearl oyster
Huang, X., Dai, J., Lin, K.-T., Liu, M., Ruan, H., Zhang, H., Liu, W., He, M., & Zhao, M. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.07.020 · Cited by 22
Li, J., & Chen, G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.12.008 · Cited by 22
The molecular basis of chaperone-mediated interleukin 23 assembly control
Meier, S., Bohnacker, S., Klose, C. J., López, A., Choe, C. A., Schmid, P. W. N., Bloemeke, N., Rührnößl, F., Haslbeck, M., Bieren, J. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12006-x · Cited by 22
Zhang, Y., Planas, D., Marchand, L. R., Massanella, M., Chen, H., Wacleche, V. S., Gosselin, A., Goulet, J.-P., Filion, M., Routy, J., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00902 · Cited by 22
Zheng, Q., Xu, F., Yang, Y., Sun, D., Zhong, Y., Wu, S., Li, G., Gao, W., Wang, T., Xu, G., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000384r · Cited by 22
RNA‐Seq analysis of the guppy immune response against Gyrodactylus bullatarudis infection
Konczal, M., Ellison, A., Phillips, K. P., Radwan, J., Mohammed, R. S., Cable, J., & Chadzińska, M. (2020) · Parasite Immunology · doi:10.1111/pim.12782 · Cited by 22
“Furthermore, in mammals also IL-23 induces a polarization of Th17 cell population with a unique inflammatory gene signature that includes IL17, IL6, TNF, CCL20, CCL22, IL1R1, and IL23R (69).”
Tricyclic-Carbocyclic RORγt Inverse Agonists—Discovery of BMS-986313
Yang, M. G., Bertrand, M. B., Xiao, Z., Marcoux, D., Weigelt, C. A., Yip, S. H., Wu, D., Ruzanov, M., Sack, J. S., Wang, J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01992 · Cited by 22
Jin, X., Xu, H., Huang, C., Ma, H., Xiong, X., Cheng, L., Wang, F., Feng, Y., & Zhang, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749626 · Cited by 22
“Although the pathogenesis of psoriasis is not totally understood, interleukin-23 (IL-23)/T helper 17 (TH-17) axis is believed to be critically involved in the development and maintenance of psoriasis (Gaffen et al., 2014; Schinocca et al., 2021).”
BackgroundRegulation of Drug-Metabolizing Enzymes and Drug Metabolism by Inflammatory Responses
Morgan, E. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802949-7.00002-x · Cited by 22
Asuri, S., McIntosh, S., Taylor, V., Rokeby, A., Kelly, J. K., Shumansky, K., Field, L. L., Yoshida, E. M., & Arbour, L. T. (2018) · Liver International · doi:10.1111/liv.13686 · Cited by 22
Sun, G., Xing, C., Zeng, L., Huang, Y., Sun, X., & Liu, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/5790291 · Cited by 22
Huang, H., Yang, C., Li, S., Huang, Z., Tan, J., Chen, C., Li, J., Wang, M., & Li, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119958 · Cited by 21
Th17 cells in cancer: plasticity‐driven immunopathology and therapeutic opportunity
Sutanto, H., Ningtyas, M. C., Rachma, B., Pratiwi, L., & Fetarayani, D. (2025) · Immunology and Cell Biology · doi:10.1111/imcb.70043 · Cited by 21
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.